Posts With Tag NASDAQ VTGN

Showing 1 - 3 of 3 Posts

Vistagen Therapeutics 8-K Report: Key Updates for Investors - February 2025

$VTGN

•

Form 8-K

•

2025-02-13

Last updated: 3 months ago

Vistagen Therapeutics 8-K Report: Key Updates for Investors - February 2025

Explore Vistagen Therapeutics' 8-K filing detailing significant updates as of September 23, 2024. Stay informed on corporate developments and stock insights.

Vistagen Therapeutics biotechnology NASDAQ VTGN financial reporting 8-K filing

Vistagen Therapeutics, Inc. 8-K Report: Key Developments and Insights

$VTGN

•

Form 8-K

•

2025-01-14

Last updated: 4 months ago

Vistagen Therapeutics, Inc. 8-K Report: Key Developments and Insights

Explore Vistagen Therapeutics' latest 8-K report filed on January 14, 2025, detailing crucial updates and corporate changes that impact VTGN investors.

Vistagen Therapeutics Biotechnology NASDAQ VTGN SEC Filings Common Stock

Vistagen Therapeutics, Inc. Form 8-K Report: Key Insights and Updates

$VTGN

•

Form 8-K

•

2025-01-13

Last updated: 4 months ago

Vistagen Therapeutics, Inc. Form 8-K Report: Key Insights and Updates

Explore Vistagen Therapeutics' Form 8-K filed on January 10, 2025, detailing significant events and stock information. Stay informed on VTGN's latest developments.

Vistagen Therapeutics Form 8-K biotechnology NASDAQ VTGN financial reporting